Jacob Lang
Optometrist · Stillwater, MNNPI 1053345835
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 26.6% of the total. 2025 is the largest year on record at $89,174, 4.1 times the $21,773 reported in 2019. Among optometrist clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $708.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$70K
- Sun Pharmaceutical Industries Inc.$51K
- Dompe US, Inc.$20K
- Alcon$18K
- Sparca Ltd$18K
- Novartis$16K
- plus $71K from 24 others
What the payments were for
- Consulting fees$89,43334%
- Speaking & faculty fees$141,27453%
- Travel & lodging$25,32210%
- Food & beverage$8,0383%
- Gifts$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 69 | $70,233 |
| Sun Pharmaceutical Industries Inc. | 52 | $51,413 |
| Dompe US, Inc. | 39 | $19,538 |
| Alcon | 28 | $18,052 |
| Sparca Ltd | 2 | $17,600 |
| Novartis | 21 | $16,143 |
| Bausch & Lomb Americas Inc. | 24 | $14,918 |
| AbbVie(2 entities) | 22 | $13,973 |
| Oyster Point Pharma, Inc. | 25 | $13,367 |
| Amgen | 11 | $6,643 |
| Shire North American Group Inc | 5 | $4,762 |
| Alcon Research LLC | 5 | $4,736 |
| Thea Pharma Inc. | 2 | $3,524 |
| Sight Sciences, Inc. | 17 | $2,063 |
| Carl Zeiss Meditec, Inc. | 13 | $1,838 |
| Carl Zeiss Meditec USA, Inc. | 10 | $1,491 |
| Aerie Pharmaceuticals, Inc. | 3 | $1,083 |
| Kala Pharmaceuticals, Inc. | 2 | $1,034 |
| Ocular Therapeutix, Inc. | 7 | $527 |
| Tearlab Corp | 2 | $523 |
| Biotissue Holdings Inc. | 3 | $163 |
| Quidel Corporation | 3 | $144 |
| Lumibird Medical Inc. | 1 | $103 |
| Glaukos Corporation | 1 | $75 |
| Valley Contax, Inc. | 1 | $60 |
| Rxsight Inc | 1 | $32 |
| Astellas Pharma US Inc | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Harrow Eye, LLC | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$58,955
- CEQUA$50,755
- XIIDRA$20,715
- TRYPTYR$17,918
- TYRVAYA$12,945
- TEPEZZA$6,385
- Oxervate$4,529
- RESTASIS$2,550
- CIRRUS HD-OCT$2,413
- BIOTRUE ONE DAY$2,100
- CLARUS$1,800
- TEARCARE SYSTEM$1,495
- DEXTENZA$1,448
- FORUM$1,129
- EYSUVIS$1,010
- Rocklatan$1,008
- ATLAS 500$1,000
- VUITY$909
- DAILIES$864
- CIRRUS 6000 with AngioPlex$800
How this compares
$264,126 in reported general payments places this provider in the 95th percentile of 826 optometrist providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 20 | $565,204 |
| XiidraLifitegrast | 159 | $227,869 |
| RestasisCyclosporine | 167 | $221,604 |
| MieboPerfluorohexyloctane/Pf | 77 | $60,407 |
| TyrvayaVarenicline Tartrate | 48 | $59,245 |
| XdemvyLotilaner | 23 | $43,476 |
| Cyclosporine | 68 | $36,585 |
| CequaCyclosporine | 35 | $30,330 |
| Fluorometholone | 413 | $25,034 |
| Loteprednol Etabonate | 141 | $18,308 |
| LumiganBimatoprost | 26 | $17,716 |
| EysuvisLoteprednol Etabonate | 29 | $14,356 |
| Prednisolone Acetate | 146 | $4,480 |
| Latanoprost | 142 | $2,273 |
| MoxifloxacinMoxifloxacin Hcl | 56 | $1,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $19,538 | $565,20420 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $14,918 | $288,277236 claims |
| AbbVieRestasis, Lumigan | $13,973 | $239,319193 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $13,367 | $59,24548 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $70,233 | $43,47623 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $51,413 | $30,33035 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $18 | $18,308141 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $1,034 | $14,35629 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 826 optometrist providers in Minnesota.
Other optometrist in Stillwater
- Britt GustafsonEden Prairie$236K
- Gina WesleyMedina$232K
- Nicholas ColatrellaSartell$84K
- Trevor FossoSartell$45K
- Mathew WalkerAlexandria$43K
- Joshua HanenMinneapolis$40K
- Zachary HollandEdina$36K
- Patrick WellikApple Valley$15K
- Paul HammondCoon Rapids$14K
- Patrick MartinBurnsville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.